当前位置：首页 > 文献互助 > 互助详情

期刊论文Xanomeline/Trospium Chloride: First Approval复制

用户_3gesBYkXd2E 1小时前 16 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-07 09:10:57 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

文献链接:复制

其他信息:

互助时间线

楼主确认了期刊精灵应助的文件是正确的, 求助状态变成已完结

期刊精灵上传了文件(pdf 795.73 KB), 求助状态变成待确认

Olanzapine. Pharmacokinetic and pharmacodynamic profile 13分钟前

The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. 37分钟前

The ESG-Innovation Disconnect: Evidence from Green Patenting 39分钟前

The ESG-Innovation Disconnect: Evidence from Green Patenting 49分钟前

From risk to sustainable opportunity: Does climate risk perception lead firm ESG performance? 52分钟前

Artificial intelligence and corporate ESG performance: evidence from China 1小时前

Xanomeline/Trospium Chloride: First Approval 1小时前

Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer 1小时前

H-Terminated Catellani Strategy to Aryl β-Ethanol Enables Collective Total Syntheses of Pyranonaphthoquinone Natural Products 1小时前